These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8613768)

  • 21. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.
    Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U
    Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum].
    Adachi Y; Wada H; Higuchi H; Watanabe K; Satoh T
    Masui; 2001 Oct; 50(10):1089-95. PubMed ID: 11712340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo.
    Moison D; De Deurwaerdère P; Cagnotto A; Marrazzo A; Prezzavento O; Ronsisvalle G; Mennini T; Spampinato U
    Neuropharmacology; 2003 Dec; 45(7):945-53. PubMed ID: 14573387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
    See RE
    Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
    Andrés ME; Gysling K; Bustos G
    Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study.
    Alfonso M; Durán R; Campos F; Perez-Vences D; Faro LR; Arias B
    Neurochem Res; 2003 Oct; 28(10):1487-93. PubMed ID: 14570393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
    Kihara T; Ikeda M; Matsushita A
    Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation by choline of basal and electrically evoked acetylcholine release, as studied using a novel device which both stimulates and perfuses rat corpus striatum.
    Farber SA; Kischka U; Marshall DL; Wurtman RJ
    Brain Res; 1993 Apr; 607(1-2):177-84. PubMed ID: 8481795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo characterisation of extracellular dopamine, GABA and acetylcholine from the dorsolateral striatum of awake freely moving rats by chronic microdialysis.
    Osborne PG; O'Connor WT; Kehr J; Ungerstedt U
    J Neurosci Methods; 1991 Apr; 37(2):93-102. PubMed ID: 1679148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal interaction among dopamine, glutamate and ascorbate.
    Morales I; Fuentes A; Ballaz S; Obeso JA; Rodriguez M
    Neuropharmacology; 2012 Dec; 63(8):1308-14. PubMed ID: 22959966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
    Grimm JW; See RE
    Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents.
    Campbell K; Kalén P; Wictorin K; Lundberg C; Mandel RJ; Björklund A
    Neuroscience; 1993 Mar; 53(2):403-15. PubMed ID: 8098510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
    Rothblat DS; Schneider JS
    Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcholinesterase inhibitors block acetylcholine-evoked release of dopamine in rat striatum, in vivo.
    Dajas-Bailador F; Costa G; Emmett S; Bonilla C; Dajas F
    Brain Res; 1996 May; 722(1-2):12-8. PubMed ID: 8813345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
    Zhang W; Tilson H; Stachowiak MK; Hong JS
    Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.
    Morari M; O'Connor WT; Ungerstedt U; Fuxe K
    Eur J Pharmacol; 1994 Apr; 256(1):23-30. PubMed ID: 7913045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.